3 Diabetes Biotechs That Could Surge 50% or More in 2018 Post author:Sam Post published:January 21, 2018 Post category:BioPharma Wall Street projects these three biotechs will grow the fastest over the next 12 months. Source: BioSpace You Might Also Like <b>StoneCalibre</b> Affiliate Acquires In-Vitro Diagnostics Products Provider <b>Alpha-Tec Systems</b> July 18, 2017 Kendall Square Upstart Comes Out of Stealth Mode With $26 Million January 23, 2017 Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals February 23, 2017
<b>StoneCalibre</b> Affiliate Acquires In-Vitro Diagnostics Products Provider <b>Alpha-Tec Systems</b> July 18, 2017
Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals February 23, 2017